| | LOC129992561, LOC129992562 +1409 more | Copy number gain | Neurodevelopmental disorder | |
| | | Copy number gain | See cases | |
| | LOC129389216, LOC129389217 +757 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | ENAM, LOC123477761 +360 more | Copy number loss | Piebaldism | |
| | LOC129992618, LOC129992619 +143 more | Copy number gain | See cases | |
| | | Single nucleotide variant | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Deletion (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Deletion (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Microsatellite (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Deletion (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Duplication (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan | |
| | | Single nucleotide variant (3 prime UTR variant) | Qualitative or quantitative defects of beta-sarcoglycan +1 more | |
| | LOC129992584, LOC129992585 +1 more | Duplication | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (3 prime UTR variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | LOC129992584, LOC129992585 +1 more | Deletion | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (missense variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (missense variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (missense variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Deletion (inframe_deletion) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (missense variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (missense variant) | not provided | |
| | | Single nucleotide variant (missense variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (missense variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (missense variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |
| | | Single nucleotide variant (synonymous variant) | Autosomal recessive limb-girdle muscular dystrophy type 2E | |